ANIP
ANI Pharmaceuticals Inc
74.00$
-0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.4% | 22.6% | 21.4% | 22.3% | 33.3% | 22.1% | 7.3% | 1.5% | -9.9% | 24.4% | 10.4% | 21.0% | |
| 6.9% | 9.0% | 17.4% | 15.8% | 16.7% | 21.6% | 21.4% | 21.9% | 18.9% | 12.3% | 11.0% | 10.3% | |
| 6.1% | 5.1% | 4.7% | 3.4% | 3.4% | 4.5% | 6.2% | 4.9% | 4.6% | 4.2% | 4.8% | 4.3% | |
| -18.7% | 2.6% | 3.0% | 6.0% | 1.7% | 1.2% | 1.9% | -1.7% | 0.1% | – | – | – | |
| -0.2% | -18.2% | -7.7% | -3.2% | 3.0% | -7.1% | -6.1% | 0.0% | -16.2% | 5.1% | -1.8% | -0.8% | |
| 63.9% | 42.8% | 115.9% | 61.1% | 5.4% | 13.3% | 32.8% | 10.9% | 5.2% | 3.8% | 2.8% | 3.9% | |
| -63.9% | -42.8% | -119.8% | -61.1% | -13.6% | -13.3% | -32.8% | -48.8% | -5.0% | -3.8% | -65.9% | -3.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 2.8% | 0.3% | 0.1% | 0.5% | 0.3% | 0.3% | 0.1% | |
| 58.3% | -0.1% | -2.0% | -0.1% | -0.3% | -0.5% | -0.7% | -0.4% | -0.6% | -1.0% | -1.8% | -1.4% | |
| 247.0% | 98.3% | -0.2% | 40.9% | -14.4% | -58.8% | -0.3% | 45.8% | -0.9% | -0.6% | 56.2% | -1.1% | |
| 306.7% | 1.4% | -0.6% | 40.9% | -13.8% | 0.6% | -0.7% | 90.0% | -1.6% | 13.9% | 43.1% | -1.1% | |
| 282.2% | -18.8% | -99.0% | 2.1% | 5.9% | 9.4% | -26.1% | 42.8% | -16.5% | 34.5% | -12.4% | 15.9% | |
| -24.5% | -20.2% | -94.5% | -38.8% | 27.9% | 8.8% | -25.4% | -9.4% | -15.1% | 20.6% | 7.7% | 17.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.